The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2:81:367-371. doi: 10.1016/j.pnpbp.2017.09.001. Epub 2017 Sep 5.
No abstract available

Keywords: MPTP; Parkinson's disease; dyskinesia; marmoset; mianserin; psychosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Callithrix
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / etiology
  • Female
  • Levodopa / adverse effects
  • MPTP Poisoning / drug therapy
  • Male
  • Mianserin / therapeutic use*
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / etiology*
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Antidepressive Agents, Second-Generation
  • Mianserin
  • Levodopa